Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Orthocell Ltd ( (AU:OCC) ) has shared an announcement.
Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir nerve repair device in the United Kingdom, a move that underpins its strategy to penetrate the UK and EU peripheral nerve repair market estimated at US$750 million annually. LEDA, a specialist orthopaedic distributor with more than 40 sales representatives and strong surgeon relationships, will begin pre-launch activities such as surgeon engagement, medical education and hospital procurement planning while Orthocell awaits anticipated UK/EU regulatory approval in Q3 FY26.
The UK rollout will be supported by Orthocell’s Australian-based commercial and medical education teams, leveraging programs and clinical evidence that have driven successful launches in Australia and the United States. With Remplir already approved and selling in multiple markets including Australia, New Zealand, Singapore, the US and Hong Kong, and first Canadian sales expected in the near term, Orthocell’s approximately $49 million in cash reserves provide a strong balance sheet to execute its global distribution strategy and accelerate commercial adoption in new territories.
The most recent analyst rating on (AU:OCC) stock is a Sell with a A$0.84 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd is an Australian regenerative medicine and medical device company focused on orthopaedic and nerve repair technologies. Its flagship product Remplir is used in peripheral nerve repair procedures, targeting a sizeable global market for complex upper limb and nerve-related surgeries, with a growing commercial footprint across Asia-Pacific and North America.
Average Trading Volume: 427,912
Technical Sentiment Signal: Hold
Current Market Cap: A$240.1M
See more insights into OCC stock on TipRanks’ Stock Analysis page.